The new data may surprise you.  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏




View in browser
<[link removed]>
||UNSUBSCRIBE
<[link removed]>

<[link removed]>


<[link removed]>





Hello John,

‌

If you asked anyone about prescription drug prices in the United States versus
those in other industrialized nations, most people would say that Americans pay
more for drugs than people in those other countries.

And when it comes to new, patented drugs, that’s true.

But that’s not the whole story: A new study
<[link removed]>
by our friend Tomas Philipson found that when it comes to generic drugs —
off-patent drugs subject to competition — the situation is quite different. In
fact, Americans are better off than people in other countries.

New, brand-name drugs are often pricey because they have patents — temporary
monopolies granted by the government. A patent ensures that the company that
made the drug can recoup the enormous cost that goes in to bringing a new drug
to market. It is also a key reason why the American pharmaceutical industry is
the most innovative and advanced in the world.

‌

💊 The truth is, America actually leads on generic drug prices.

Philipson examined both brand-name and generic drugs across six developed
countries: the United States, Canada, Germany, the United Kingdom, France, and
Japan. He found that the United States has “both a higher share of generic
prescriptions and lower generic prices than other countries.”

Generics make up a much larger portion of the U.S. market (93%), and generic
drugs in peer countries cost around twice as much as those in the United States.

The result?

As the study notes: “U.S. public-sector [Medicare and Medicaid] prescription
net prices are 18% lower on average than those in the peer countries. This
challenges the common viewpoint that the U.S. drug prices are universally
higher.”

‌

This is a big deal.

In America, generic drugs are much less expensive than generics sold in other
countries. And they represent the vast majority of the drugs we Americans use.
The claim that American consumers are being “ripped off” by foreign governments
is greatly exaggerated.

🚀 Want to expand America’s drug innovation to new heights? Well, government
regulations and price controls aren’t the answer ...

These important new findings should give pause to proponents of government
price controls for prescription drugs. We do not need price fixing to reduce
drug costs. Price controls stifle lifesaving innovation and cause harmful
shortages, ultimately driving drug prices higher. Going down that road would
imperil Americans’ access to breakthrough treatments and our ability to get the
latest medicines before the rest of the world.

‌

Breakthroughs don’t come cheap: It takes 10 to 15 years and $2.6 billion on
average to bring a new drug to market. This creates an unavoidable tradeoff
between profitability and innovation.

* Allowing the government to set drug prices would only further stifle
innovation.
* Instead of price controls, Washington should promote competition and end
the red tape that makes drugs more expensive, which is an integral part of our
Personal Option health care proposal.
The Personal Option contains policies like a streamlined drug approval process
to reduce development costs, expanded availability of tax-free health savings
accounts that give patients more control, and the removal of needless barriers
to lower-cost generics.

‌

Here are other ways that the Personal Option would specifically bring down
drug prices for all Americans:

* Boost the number of drugs available over the counter without a doctor’s
prescription.
* Streamline FDA drug approvals to give patients and doctors more options
without sacrificing safety.
* Repeal rules that grant drug companies undeserved patent extensions that
keep medicine prices high.
* Repeal existing government price controls and resist new ones.
You can help promote the Personal Option by signing
<[link removed]>
our Personal Option Petition. When you do, you’ll join millions of Americans
advocating for a transparent, patient-first health care system that works for
people.


Sign the petition
<[link removed]>



Thank you for being part of this critical effort.

Best regards,

‌

- Dean

‌

Dean Clancy
Senior Health Policy Fellow
Americans for Prosperity






Thank you for your continued support. Together, we’re ensuring every American
has access to the health care solutions they need. Stay tuned for updates on
how we’re making impact-driven changes possible.






Americans for Prosperity

4201 Wilson Blvd, Suite 1000

Arlington, VA 22203



This email was sent to:

[email protected]




UNSUBSCRIBE
<[link removed]>
•PRIVACY POLICY
<[link removed]>
•VIEW ONLINE
<[link removed]>


<[link removed]>